Seeking Alpha

Perrigo (PRGO) says its received final FDA approval for its clobetasol propionate shampoo, the...

Perrigo (PRGO) says its received final FDA approval for its clobetasol propionate shampoo, the generic equivalent of Clobex Shampoo for the treatment of moderate to severe scalp psoriasis. The company will begin shipping immediately. Annual sales of both the generic and branded treatment total approximately $57M.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs